Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vassal

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Bulletin Du Cancer|February 10, 1999
[Methodology and limitations of pre-clinical models for the development of anticarcinogenic chemotherapy combinations]G Vassal
Bulletin Du Cancer|January 1, 1990
[Pharmacologic bases of chemotherapy of brain tumors in children]G Vassal
Anticancer Research|November 1, 1994
Pharmacologically-guided dose adjustment of busulfan in high-dose chemotherapy regimens: rationale and pitfalls (review)G Vassal
Journal of Chromatography|July 15, 1988
Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standardG Vassal, M Re, A Gouyette
Annals of Internal Medicine|June 1, 1990
Busulfan and veno-occlusive disease of the liverG Vassal, O Hartmann, E Benhamou
European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
European collaboration in trials of new agents for children with cancerS Ablett, F Doz, B Morland, et al.
Pathology Oncology Research : POR|October 8, 1998
Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapyP Canal, E Gamelin, G Vassal, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1986
[Acute lymphoblastic leukemia in Burkitt cells: clinical, therapeutic and prognostic aspects]G Vassal, G Leverger, G Schaison, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 7, 2002
[Statutory pediatric informations available for anticancer drugs: inventory and proposals]C Thouvenel, M S Gény, S Demirdjian, et al.
Pediatric Hematology and Oncology|January 1, 1987
Hyponatremia and renal sodium wasting in patients receiving cisplatinumG Vassal, H Rubie, C Kalifa, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Bulletin Du Cancer|February 10, 1999
[Methodology and limitations of pre-clinical models for the development of anticarcinogenic chemotherapy combinations]G Vassal
Bulletin Du Cancer|January 1, 1990
[Pharmacologic bases of chemotherapy of brain tumors in children]G Vassal
Anticancer Research|November 1, 1994
Pharmacologically-guided dose adjustment of busulfan in high-dose chemotherapy regimens: rationale and pitfalls (review)G Vassal
Journal of Chromatography|July 15, 1988
Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standardG Vassal, M Re, A Gouyette
Annals of Internal Medicine|June 1, 1990
Busulfan and veno-occlusive disease of the liverG Vassal, O Hartmann, E Benhamou
European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
European collaboration in trials of new agents for children with cancerS Ablett, F Doz, B Morland, et al.
Pathology Oncology Research : POR|October 8, 1998
Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapyP Canal, E Gamelin, G Vassal, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1986
[Acute lymphoblastic leukemia in Burkitt cells: clinical, therapeutic and prognostic aspects]G Vassal, G Leverger, G Schaison, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 7, 2002
[Statutory pediatric informations available for anticancer drugs: inventory and proposals]C Thouvenel, M S Gény, S Demirdjian, et al.
Pediatric Hematology and Oncology|January 1, 1987
Hyponatremia and renal sodium wasting in patients receiving cisplatinumG Vassal, H Rubie, C Kalifa, et al.
Pageof 10